
Strategic consulting support and fractional medical affairs help pharma teams in Australia navigate lean resources and rising demands. Our short-term contract solutions deliver expertise without long-term commitments.
Australian medical affairs teams face rising demands — from shaping evidence strategy and guiding launch decisions, to managing promo review and compliance. With frozen headcount, it’s easy for priorities to stall.
PharmaVerse provides fractional and short-term contract medical affairs consulting that clears backlogs and accelerates priorities. With decades of medical affairs experience across Australia and global markets, our team can help you protect compliance and credibility while keeping your affiliate aligned with global strategy and timelines.


We clear critical backlogs — from promo review to SOPs — with senior oversight on a short-term contract basis, so nothing slips through.

We’re your interim medical director, associate medical director, or medical manager on a short-term contract, giving peer-level strategic input without FTE cost.

We engage respected KOLs on a short-term contract to align endpoints, comparators, and real-world evidence with TGA, PBAC or MSAC expectations.
Medicines Australia Code- and SOP-compliant review that keeps your brand safe and on time.
Strategic copywriting, submissions, and scientific storytelling that resonate with HCPs, regulators, and payors.
Planning, facilitation, and actionable minutes that drive strategic medical decisions.
We engage trusted KOLs to uncover clinical insights, pressure-test evidence, and build advocacy ahead of PBAC/MSAC.
Fit-for-purpose SOPs that make compliance seamless.
Evidence packages, comparators, and pathways tailored for PBAC, MSAC, and TGA — trusted track record in supporting submissions.
IQVIA 2023 Launch Excellence VIII White Paper
PharmaVerse helps teams change those odds. We consulted with a rare disease sponsor facing MSAC rejections to strengthen their evidence, securing Highly Specialised Therapy funding. Trusted by biotech sponsors and local affiliates with 15+ years of Australian medical affairs experience.
Please reach us at medical@pharmaverse.com.au if you cannot find an answer to your question.
We act as your interim medical affairs team, providing senior expertise (e.g., medical director support) on-demand, without FTE costs, to clear backlogs and drive launches.
Yes, our team is well-versed in the Medicines Australia Code of Conduct, ensuring promotional reviews align with the Code and relevant TGA standards, thereby protecting your brand.
Depending on the volume and complexity, we can clear backlogs in 2-4 weeks via targeted reviews. Book a call to discuss scope and timelines.
We leverage local networks to engage trusted KOLs, boosting advocacy and HCP buy-in
Our flexible short-term contract model is cost-effective, tailored to your needs. Book a call to discuss scope and timelines.
References: IQVIA. (2023). In pursuit of medical launch excellence: Lessons for medical affairs from IQVIA’s Launch Excellence research (Launch Excellence VIII White Paper). IQVIA. https://www.iqvia.com/-/media/iqvia/pdfs/library/white-papers/iqvia-launch-excellence-viii.pdf